- Home
- BVS vs ATTO Comparison
BVS vs ATTO Comparison
Compare BVS & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BVS | ATTO |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 982.2M | 1.0B |
| IPO Year | 2016 | 2026 |
Fundamental Metrics
Financial Performance| Metric | BVS | ATTO |
|---|---|---|
| Price | $13.63 | $20.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 460.2K | 201.7K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $7.06 | N/A |
| P/E Ratio | $26.25 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.26 | $16.15 |
| 52 Week High | $15.89 | $28.00 |
Technical Indicators
Market Signals| Indicator | BVS | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 46.51 |
| Support Level | $13.44 | $18.85 |
| Resistance Level | $14.71 | $24.89 |
| Average True Range (ATR) | 0.51 | 2.62 |
| MACD | -0.08 | -0.30 |
| Stochastic Oscillator | 51.85 | 12.39 |
Price Performance
Historical ComparisonAbout BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
About ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.